Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

227.06
-1.3300-0.58%
Post-market: 227.060.00000.00%19:34 EDT
Volume:927.43K
Turnover:211.11M
Market Cap:25.06B
PE:24.11
High:229.80
Open:228.51
Low:226.81
Close:228.39
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.77
T/O Rate:0.84%
Dividend:3.32
Dividend Rate:1.46%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.33
PE(LYR):25.95

Loading ...

Quest Diagnostics Raises Annual Forecast on Testing Demand

Reuters
·
Jul 23

Quest Climbs After Raising Annual Profit Forecast

Reuters
·
Jul 23

Quest Diagnostics Lifts FY View on Higher 2Q Sales, Profit

Dow Jones
·
Jul 23

Movement Alert|Quest Diagnostics Rises 6.28% in Pre-Market Trading, Q2 Earnings Beat Estimates and Full-Year Guidance Raised

Market Focus
·
Jul 23

GUIDANCE: (DGX) Quest Diagnostics Expects Full Year 2026 Revenue Range $11.95B - $12.05B, vs. FactSet Est of $11.85B

MT Newswires Live
·
Jul 23

Quest Diagnostics reports Q2 adjusted EPS $3.12, consensus $2.82

TIPRANKS
·
Jul 23

Quest Diagnostics ups FY26 adjusted EPS view to $11.05-$11.25 from $10.63-$10.83

TIPRANKS
·
Jul 23

Quest Diagnostics Shares up 5.8% Premarket After Co Forecasts Annual Revenue, Profit Above Estimates

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Q2 FY26 Diluted EPS Rises 15% to 2.84; Revenue Increases 10.2% to 3.04 Billion

Reuters
·
Jul 23

Quest Diagnostics Q2 Adj. EPS $3.12 Beats $2.83 Estimate, Sales $3.043B Beat $2.973B Estimate

Benzinga Earnings
·
Jul 23

Stock Track | Quest Diagnostics Soars 5.32% in Pre-market on Better-Than-Expected Q2 Revenue

Stock Track
·
Jul 23

Quest Diagnostics Outlook FY EPS USD 9.97-10.17

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Q2 Revenue USD 3,043 Million VS. Ibes Estimate USD 2,967 Million

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 23

Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why

Simply Wall St.
·
Jul 17

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Buy Rating Reaffirmed on Quest Diagnostics as ACA-Related Risks Seen as Manageable and Earnings Resilient

TIPRANKS
·
Jul 16

Earning Preview: Quest Diagnostics Q2 revenue is expected to increase by 9.09%, and institutional views are bullish

Earnings Agent
·
Jul 16